Clinical trial
A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Milnacipran in the Treatment of Irritable Bowel Syndrome
NCT01471379 is registered in ClinicalTrials.gov with Spencer Dorn, MD, MPH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy of Milnacipran in the Treatment of Irritable Bowel Syndrome
- Lead sponsor
- Spencer Dorn, MD, MPH
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- April 30, 2012
- Completion date
- February 28, 2013
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.